Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

Background Extended interval dosing (EID) of natalizumab is a promising strategy to optimise treatment in multiple sclerosis (MS). Personalised EID by therapeutic drug monitoring can enable further ...

Keywords: multiple sclerosis, gut microbiome, autologous haemopoietic stem cell transplant (AHSCT), dysbiosis, immune reconstitution (IR) Citation: Yin J, Kaakoush NO, Massey J and Danta M (2025) ...

About 8 in 10 people with MS live with fatigue, according to the National Multiple Sclerosis Society (NMSS). [1] Coffee, of course, is a stimulant, and can help you feel more alert in the morning ...

A CAR T-cell therapy from Iaso Biotherapeutics was tolerated well and led to marked improvements in disability for three people with progressive forms of multiple sclerosis (MS), according to ...

DelveInsight’s multiple sclerosis competitive report depicts a robust space with 60+ active players working to develop 75+ pipeline multiple sclerosis treatments.